Search Results

Business

Aether Biomachines Appoints Erik Scher, Ph.D., to Board of Directors

Aether Biomachines, a nanotechnology company building a future of abundance, announced the appointment of True North Venture Partners’ Erik Scher, Ph.D., to its Board of Directors.

April 27, 2022

·

3 min read

BioMidwest

Aether Biomedical Announces Series A Funding Round Close, Pushes Forward Future of Upper Limb Prosthetics

Aether Biomedical, a biotech company creating cutting-edge bionic prosthetics, announced the successful conclusion of a $5.8 Million Series A funding round, led by J2 Ventures and Story Ventures.

November 13, 2023

·

5 min read

Business

Aether Biomachines Expands Board of Directors with Appointment of Ginkgo Bioworks Co-Founder Austin Che

Aether Biomachines, a leading enzyme engineering company building a future of abundance, announced the appointment of Austin Che to its Board of Directors.

December 1, 2021

·

3 min read

Aether Bio

Aether Biomedical was founded on the premise of creating healthcare technology and robotics based on human-centered design. A culture focused on building the next generation of bionic devices, utilizing cutting-edge biosignal processing and software integration.

Biotech Bay

Aether and UCL Researchers Democratizing 3D Printed Nanotech at 2% of Competitor Cost

Aether, the pioneer of AI enhanced 3D bioprinting, has announced a collaboration with researchers from University College London (“UCL”) and Loughborough University to develop a powerful new approach to 3D printing nanotechnology.

January 22, 2019

·

3 min read

Business

Aether Announces Residency at JLABS @ QB3

Today Aether, a San Francisco-based life sciences technology company, is pleased to announce it is now a resident company at Johnson & Johnson Innovation, JLABS @ QB3, located in the University of California’s QB3 @ 953 Indiana Street facility.

January 31, 2018

·

2 min read

Biotech Bay

Aether and Procter & Gamble Begin 3D Printing and AI Development Project

Enter into joint development agreement for consumer goods research technologies

February 19, 2019

·

3 min read

Business

NextGen Class of 2024: Top Life Sciences Startups to Watch This Year

Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.

January 3, 2024

·

20 min read

·

BioSpace Editorial Staff

Advanced Proteome Therapeutics Announces Its Proposed Plan of Arrangement

Advanced Proteome Therapeutics Corporation (TSXV: APC) (FSE: 0E81) (“APC” or the “Company”) is pleased to announce that the Supreme Court of British Columbia (the “Court”) has issued an interim order (the “Interim Order”) on January 16, 2023 in connection with the Company’s proposed Plan of Arrangement (see below).

January 17, 2023

·

11 min read

Business

Allogene, Progenity, Adaptive Phage Tout New Top Executives

Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers.

April 28, 2022

·

8 min read

·

Alex Keown